Type 1 diabetesType 2 diabetesDelivering insulin via the inhalation route is an exciting concept. Recent progress in inhalation technology has enabled development of inhaled insulin-delivery systems. Exubera(inhaled human in...
Needle-based delivery systems suit the vast majority of people with type 1 and type 2 diabetes who require insulin. However, a small group may be better suited to a needle-free delivery system. In the UK, GPs can now prescribe, on the NHS, such a needle-free delivery system — sometimes...
Barbara Young, chief executive of Diabetes UK, said it was a wake-up call to all concerned. “We face the real possibility of diabetes bankrupting the NHS within a generation. “This is why we need to grasp the nettle on preventing Type 2 diabetes, which accounts for around 90% of diabe...
Novel therapies with precision mechanisms for type 2 diabetes mellitus Article 04 May 2021 Tirzepatide outcompetes long-acting insulin in managing type 2 diabetes: a meta-analysis of three phase 3 randomized controlled trials Article 29 August 2024 References Bliss, M. The Discovery of Insul...
"Ali will always be a super hero to me and my family. I was diagnosed with PCOS when I was 17 and I am currently 33. My partner and I have been trying to conceive for 12 years. BMI is a big problem when trying to receive fertility treatments with the NHS. One of the side effect...
89d-903. 22. rosenstock j, et al. prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial. lancet 2010; 375: 2244-53. 23. zinman b. the physiologic replacement of insulin: an elusive goal. n engl j med...
suggest that rather than changing the insulin concentration or altering the chemistry of the peptide, simply modulating the valency and geometry of insulin nanoclusters can control IR-mediated responses and may provide a starting point for the development of new drugs for the treatment of diabetes. ...
Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet. 2020;52(7):680–91. Article CAS Google Scholar Fazeli PK, Lee H, Steinhauser ML. Aging is a powerful risk factor for type 2 ...
database research, glycaemic control, insulin therapy, type 2 diabetesAims: National Institute for Health and Care Excellence guidelines suggest premixed insulin as a treatment option for type 2 diabetes (T2D) uncontrolled (HbA1c ≥9 % [≥75 mmol/mol]) by ≥2 oral antihyperglycaemic drugs (...
Effects of oral insulin in relatives of patients with type 1 diabetes: the Diabetes Prevention Trial—Type 1. Diabetes Care. 2005;28(5):1068-1076.PubMedGoogle ScholarCrossref 3. Williams AJK, Bingley PJ, Bonifacio E, Palmer JP, Gale EAM. A novel micro-assay for insulin autoantibodies. ...